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Abstract
Background: The enthesis, which attaches the tendon to the bone, naturally disappears with aging, thus limiting joint
mobility. Surgery is frequently needed but the clinical outcome is often poor due to the decreased natural healing capacity
of the elderly. This study explored the benefits of a treatment based on injecting chondrocyte and mesenchymal stem cells
(MSC) in a new rat model of degenerative enthesis repair.
Methodology: The Achilles’ tendon was cut and the enthesis destroyed. The damage was repaired by classical surgery
without cell injection (group G1, n=52) and with chondrocyte (group G2, n=51) or MSC injection (group G3, n=39). The
healing rate was determined macroscopically 15, 30 and 45 days later. The production and organization of a new enthesis
was assessed by histological scoring of collagen II immunostaining, glycoaminoglycan production and the presence of
columnar chondrocytes. The biomechanical load required to rupture the bone-tendon junction was determined.
Principal Findings: The spontaneous healing rate in the G1 control group was 40%, close to those observed in humans. Cell
injection significantly improved healing (69%, p=0.0028 for G2 and p=0.006 for G3) and the load-to-failure after 45 days
(p,0.05) over controls. A new enthesis was clearly produced in cell-injected G2 and G3 rats, but not in the controls. Only the
MSC-injected G3 rats had an organized enthesis with columnar chondrocytes as in a native enthesis 45 days after surgery.
Conclusions: Cell therapy is an efficient procedure for reconstructing degenerative entheses. MSC treatment produced
better organ regeneration than chondrocyte treatment. The morphological and biomechanical properties were similar to
those of a native enthesis.
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Introduction
Population aging and a better quality of life have led to surgery
now being performed on elderly patients who are still very active.
The two main orthopedic surgical procedures are joint replace-
ment in cases of osteoarthritis (OA) and the repair of failed tissues.
The repair of many joints is particularly challenging in elderly
patients because this surgery depends on the natural healing
capacity of the body and older people heal more slowly [1].
Tendons and ligaments are fibers made up of dense connective
tissue and they are critical for physiological movement and the
stability of joints because of their attachment to bone [2]. Injury to
these structures can significantly destabilize joints, resulting in the
development of degenerative joint diseases, especially in the upper
limbs [2]. The most common disorders affect the supraspinatus
tendon of the rotator cuff, the Achilles tendon, the flexor tendons
of the hand, and the anterior cruciate and medial collateral
ligaments of the knee [3,4]. Almost 60% of people over 60 suffer
from a torn shoulder tendon [3,5]. Current clinical data indicate
that 50% of surgically repaired shoulder cuff tears do not heal
properly [3,5,6]. These poor healing rates are independent of the
surgical procedure used [6–8] and the poor healing is statistically
linked to a negative clinical outcome [6]. Several extrinsic and
intrinsic mechanisms have been proposed to explain the
development of rotator cuff disease [3,9–11]. One reason for this
failure after repair is the age of the surrounding tissues. Fresh,
limited lesions heal more rapidly in healthy patients [6].
Unfortunately, rotator cuff disease usually occurs in the elderly,
who obviously have aging tissues [9]. Adipose tissue infiltrates the
muscles, structural disorders appear in tendon, mineral changes
affect the humeral head, and the enthesis disappears [5]. The
enthesis is delimited by the region covering the tendon-to-bone
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the tendon zone (organizing the anchoring of tendon type I
collagen fibers arriving at the enthesis), the unmineralized
fibrocartilage, the mineralized fibrocartilage and the bone. The
calcification front is the boundary between the two fibrocartilage
zones [4]. This four-layer structure is a biomechanical organ
transmits loads and decreases the concentration of stress at the
attachment zone, acting like a tectonic plate [4]. Many elements
are involved in this particular biomechanical function, but a main
one is the presence of chondrocytes producing type II collagen
[4,11]. Aging or acute trauma can cause the tendon to become
detached from the bone by breakdown or destruction of the
enthesis [5,10,11].
The high failure rate after repair is independent of the technical
procedure used. Hence, orthopedic research has focused on ways
to enhance the healing rate [7,8,12–15]. Both cell therapy and
tissue engineering have been investigated [12–15]. Several animal
studies have explored the use of adjuvants like soft tissue allografts
and allogenic growth factors to enhance bone-tendon healing [15–
18]. One possibility is to use an allogenic scaffold. Cells may be
embedded in it to reinforce anchoring or to increase the size of the
tendon [17]. Whereas animal studies have reported improvements
in load-to-failure, early clinical studies did not reproduce this effect
[13,14,17]. Another avenue of research is to use recombinant
growth factors to promote and enhance the natural ability of the
bone to repair the tendon [15]. Experiments using BMP in bone-
tendon fixation on sheep showed that it tends to increase load-to-
failure in biomechanical tests performed 6 to 12 weeks after repair
[15]. Because natural bone-tendon fixation involves a fibrocarti-
lage [4] several authors [19] have studied the effect of implanting
cultured chondrocytes between the bone and tendon. But they
reported only histological data and no biomechanical tests were
performed. One of the main reasons for the paucity of data on cell
therapy in bone-tendon healing is the lack of a suitable animal
model.
The first aim of this study was to develop and validate a small
animal model for exploring the capacity of cell treatment to restore
the enthesis. Cell therapy is difficult to use on the rat supraspinatus
[20] and there are many data on the biomechanics of the Achilles’
tendon and calcaneus of Wistar rats. We therefore developed a
model based on the destruction of the enthesis of the Achilles’
tendon. The model needed to have a spontaneous healing rate
after repair of the bone-tendon junction of 50%, similar to human
surgical outcomes. The second part of this study evaluates the
effect of depositing chondrocytes or mesenchymal stem cells
(MSCs) during the initial repair. Chondrocytes are the natural cells
of the enthesis and can produce type II collagen, the major
promoter of anchorage. Because the body contains few chondro-
cytes, we evaluated the capacity of MSCs to produce the same
effect as chondrocytes.
Results
Experimental model of Achilles’ tendon repair
This study was approved by the animal research committee of
our university and all animal experiments complied with the
guidelines of the Institutional Animal Care and Use Committee.
The enthesis, the area of bone-tendon junction (Fig. 1A, B), is
made up of two areas that stain positively for collagen II. These
correspond to the insertion of the tendon into the bone (E1) and
the sliding zone of the tendon (E2) (Fig. 1C). The tendon healing
model required the destruction of the enthesis followed by the
attachment of the tendon to the bone using bony tunnels with
sutures (see Material and Methods). The surgical procedure totally
destroyed the enthesis, as evidenced by the absence of both tendon
and collagen II-positive fibrocartilage (Fig. 1D). In contrast, the E2
cartilage was present after the destruction of the enthesis. Healing
failure was evaluated at sacrifice by three macroscopic criteria: 1)
the proximal migration of the tendon with a gap between the
tendon and the bone, 2) suture rupture (Fig. 1E, F), and 3) the
distance between the bone and the muscle of .1 cm. These
criteria gave an overall healing rate of 40% (control group G1)
(Fig. 1G). The healing rate of our model is therefore similar to that
of human shoulder cuff surgery [3].
Improvement in overall healing rate by chondrocyte and
MSC cell therapy
Rat chondrocytes (group G2, n=51) or MSCs (group G3,
n=39) were injected into the repair site before tightening the
suture to determine the effect of cell therapy on the healing rate
after enthesis destruction and repair. The overall percentage of
healing was significantly higher than in the G1 control group when
both chondrocytes and MSCs were injected (Fig. 1G). Only 40%
of the tendons healed when no cells were injected (control group
G1, n=52), whereas the healing rate rose to 69% for the two
groups of cell-treated rats (p=0.0028 between G2 and G1, and
p=0.006 between G3 and G1). There was no statistically
significant difference between G2 and G3 (p=0.9). Both cell
therapies increased the overall tendon-to-bone healing rate after
surgical repair.
Influence of cell therapy on the load-to-failure 45 days
after repair
The load-to-failure is the load required to rupture the bone-
tendon junction. Rupture was obtained 15 days after surgery with
a significantly lower load in the control G1 group (35.9613.4N)
than in an uninjured enthesis (74.4610.9 N, p=0.001) (Fig. 2).
The injection of neither chondrocytes (40.569.5 N, p,0.001) nor
MSCs (39.668.7 N, p,0.0001) improved the load-to-failure after
15 days. The values were similar to those for the G1 group and
significantly lower than those for the native enthesis (Fig. 2). The
load-to-failure values increased with time after surgery in all three
groups of rats and reached a plateau between days 30 and 45 for
the G1 group. The G2 and G3 rats did not reach this plateau and
the load-to-failure values increased further between days 30 and
45. The load-to-failure values 45 days after repair were
significantly higher in chondrocyte-injected G2 (80.3613.0 N)
and MSC-injected G3 (84.6617.1 N) groups than in the G1 rats
(68.7615.1 N) that had been given no cells (Fig. 2). The load-to-
failure values for the two cell-injected groups 45 days after repair
were also higher than those of native entheses. Thus, cell therapy
improved the strength of the repaired tendon.
Restoration of a native-like enthesis by MSC-injection
No collagen II imunostaining was detected in control G1 group
of rats 15 and 30 days after surgery and only a faint positive
staining was observed on day 45 (Fig. 3a, d and g), although there
was fibrous tissue throughout the healing process. Alcian blue
staining did not reveal any glycoaminoglycan (GAG) in the G1
repairs 45 days post-surgery (Fig. 3g inset). The histological scale of
enthesis production (table 1) indicated that no enthesis was
restored when no cells were injected. In contrast, the bone tendon
junctions of cell-injected rats showed collagen II deposits as early
as 15 days post-repair (Fig. 3b and c). There was collagen II-
positive staining around local cell clusters that delimitated the
bone-cartilage junction in both G2 and G3 rats (Fig. 3b, c and e
insets). The numbers of cells in the clusters decreased over time,
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PLoS ONE | www.plosone.org 2 August 2010 | Volume 5 | Issue 8 | e12248Figure 1. Enthesis structure and healing ratse after repair. The enthesis is the area of bone-tendon junction. A) Wistar rat Achilles tendon-
bone junction. B) Higher magnification of the delimited area shown in (A). T, tendon; Bo, bone. C and D) Type II collagen immunostaining of a native
(C) and a destroyed enthesis (D). Native enthesis shows two positive areas of collagen II staining: E1, the insertion of the tendon (T) into the bone (Bo)
and E2, the sliding zone of the tendon. Note the absence of the tendon and the E1 area just after destruction of the enthesis (D). (C and D, scale
=200mm). E and F) Healing failure after repair was evaluated by suture breakage (E) and a distance between the bone and the tendon of greater than
1 cm (F) (E and F, scale =1 cm). G) Healing rate was evaluated at sacrifice for the three groups of rats and expressed as a percentage. * p,0.05 and
** p 0.01.
doi:10.1371/journal.pone.0012248.g001
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A second histological analysis was performed at 45 days to assess
the morphological organization of the entheses (table 1). The cells
at the bone-cartilage junction were organized into columns in the
MSC-injected G3 rats (Fig. 4D). Native entheses contained
similarly organized chondrocytes (Fig. 4A). In contrast, the
enthesis of neither the G2 nor the G1 rats had this columnar
chondrocyte distribution at the cartilage-bone junction 45 days
after repair (Fig. 4B and C). Quantification of the organization of
the enthesis showed statistically significant differences between the
native enthesis and G1 (p=0.008), between the G3 enthesis and
G1 (p=0.027), between the native and G2 entheses (p=0.005)
and between the G3 enthesis and G2 (p=0.05), whereas the
differences between the native and G3, or G1 and G2 entheses
were not significantly different. Thus, the histological appearance
of the enthesis injected with MSCs at 45 days was similar to that of
the native enthesis, but not any of the others (Fig. 4).
Discussion
Repair of tendon-bone insertion is a very common surgical
procedure, especially for shoulder cuff disorders or anterior cruciate
ligamentreconstruction.Itisoneofthemostcommonproceduresin
sports medicine [3,5,11]. Shoulder cuff surgery results in a scar, but
40 to 80% of interventions fail to repair the problem because no
healing occurs [3]. Animal models using sheep, rabbits, dogs and
rats have therefore been developed to test adjuvant therapies [21–
24]. The sheep model developedby Gerber et al. [23] can develop a
fatty infiltration of the muscle after tendon release, as in the human
shoulder. Rodeo et al. [18]and Gerber et al. [23] bothreported that
the tendon heals naturally after release, even without sutures, by
producing a neo-tendon. This makes it difficult to determine exactly
where the initial tendon was located under second-look surgery.
Rodeo et al. [18] explored the effect of local growth factors on sheep
supraspinatus tendon repair. The tendons were systematically torn
with the formation of a neo-tendon between the released tendon
and the humerus head. The same problem was reported for a rabbit
cuff model [24]. However, without healing criteria, it was not
possible to determine whether the healing was induced by the
adjuvant therapy or by the natural healing ability of the tendon.
It was necessary to develop an animal model to assess the overall
healing rate, the main clinical outcome after surgery. Our rat
Achilles tendon model is more similar to human shoulder tendons
than is the rat supraspinatus tendon used by Galatz et al. [22]. It is a
longtendon that is readily exposed because itlies just undertheskin.
It is inserted into the bone via an enthesis and attached to a well-
identified muscle. It is easy to work on, and many animals can be
tested because it is not expensive. The criteria of failure are easy to
assess. They are: migration of the tendon proximally with a gap
between the tendon and the bone, suture breakage, and a distance
between the bone and the muscle of over 1 cm. These criteria are
reproducible (with inter- and intra-observer coefficients of correla-
tionof100%)without anyspecifictraining.Theyalsohad anoverall
healing rate of 40% after enthesis destruction, which is close to the
human rate, and are convenient for evaluating the effects of
adjuvant therapy on healing. This is, to our knowledge, the only
animal model that can be used to evaluate the overall healing rate.
Reports published to date on bone-tendon healing have only
explored the load-to-failure rate [13–15,18,21–24]. It is very
important to destroy the enthesis. Murrell studied rats whose
Achilles tendon had been severed and reported that there was no
biomechanical difference between rats who had undergone surgical
repair and those who had not. Natural healing occurred within 15
days,asinotheranimalmodels.Similarly,therewasnodifferencein
the load-to-failure at 15 days in our animals, but the overall healing
rates were different [25]. Most of our tendon-bone insertions failed
at the enthesis during mechanical tests. Those that failed at the
tendon were not included in the data analyses. We demonstrate the
importance of enthesis destruction in our model to obtain a global
healing rate close to the human rate.
The challenging for regenerative medicine is to develop models
as similar as possible to degenerative age-related changes in
Figure 2. Improvement by cell therapy of the load-to-failure after repair of Achilles tendons. We determined the Load-to-failure of
Achilles tendons taken from control (G1), chondrocyte- (G2) and MSC-injected (G3) rats 15, 30 and 45 days after repair and compared them to those
of a native enthesis (74.4610.9 N, white box). There was a statistically significant difference between the value for the native entheses and those for
other populations at 15 days post-repair. There was a statistically significant difference between the values for the native enthesis and those of G1
and G3 30 days post-repair, and a statistically significant difference between G1 and G2 and G3, 45 days post-repair. * p,0.05, ** p,0.01 and
*** p,0.001.
doi:10.1371/journal.pone.0012248.g002
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aging joint disease, is the destabilization of the medial meniscus in
young mice [26]. We have used a similar approach by surgically
destroying the enthesis.
Gulotta et al. [27] explored the effect of applying bone marrow-
derived MSCs in a fibrin glue gel to rat shoulders after
supraspinatus repair. They found that there was no difference in
the load-to-failure for the group injected with MSCs and the group
without cell at 30 days, but they did not explore the effect 15 days
later. We found a significant difference in the load-to-failure data
at 45 days for the rats without cells and those that had be injected
with cells. The values for the rats given cell injections were higher.
Thus injecting cells (chondrocytes or MSCs) produces a mechan-
ically stronger insertion than does surgery alone.
Histological examination revealed that the local injection of
chondrocytes or MSCs stimulated the production of a neo-enthesis
at the bone-tendon junction, and that this did not occur after
surgery alone. It is not clear whether the chondrocytes at the bone-
tendon junctions of the rats given chondrocyte injections were the
same as those injected during surgery. They may have come from
the calcaneus bone, or from local or general differentiated MSCs.
We used chondrocytes to evaluate the effect of cell therapy on
bone-tendon healing because they are natural components of the
enthesis. They are likely to stimulate bone-tendon healing because
they are currently used in clinical practice to produce cartilage
[28]. There are reports that chondrocytes can develop the
histological appearance of an enthesis when they are placed
between a bone and a tendon [19]. Weinand [29] demonstrated
that swine chondrocytes placed in an avascular lesion of the
meniscus helped the meniscus to heal. But because chondrocytes
are rare and difficult to obtain and tend to dedifferentiate in
monolayer cultures, we examined the effects of bone marrow-
derived MSCs, as they are progenitors of chondrocytes [30].
Gulotta et al. [27] found no difference in the histological
production of an enthesis in 2 groups of tendon repairs, one with
and the other without MSC injection during repair. They noted
the organization of a fibrocartilage with time, but no histomor-
phometric analysis was performed at 45 days, as the study stopped
Figure 3. Enthesis production induced by cell therapy after repair. Immunostaining of collagen II in the enthesis of control G1 rats (a, d, g),
chondrocyte-injected G2 rats (b, e, h) and MSC-injected G3 rats (c, f, i) 15, 30 and 45 days after repair. There was no collagen II staining of G1 control
enthesis on day 15 (a), whereas the bone-tendon junction of cell-injected rats was positively stained (b, c). Chondrocyte- (b) and MSC-treated repairs
(c) also contained large aggregates of cells on top of the bone that corresponded to injected cells. (b, c insets) Higher magnification views of
delimited areas showing cell aggregates. There was no type II collagen matrix detected in the repairs without cells on day 30 (d). Cell therapy was
associated with the deposition of a collagen II matrix, which appears to be more abundant when chondrocytes were injected (e) than when MSCs
were used (f). Insert in (e) is a higher magnification view of the delimited area of the corresponding panel, showing cell aggregates close to the
collagen II matrix at the bone-tendon junction 30 days post repair. There was neither type II collagen matrix (g) nor GAG (g, inset) in the G1 repairs
without cells 45 days post repair. In contrast, a homogeneous collagen II- and GAG-rich matrix covered the bone at the tendon insertion in the cell-
injected rat (h, i). Insets (g-i) show alcian blue staining of GAG in the delimited area in the corresponding panel. Bone (Bo) is localized at the base of
the image and tendon (T) above it. Tendon and bone areas are delimited by dotted lines. Stars show the hole left by the suture used for repair. Scale
=200mm.
doi:10.1371/journal.pone.0012248.g003
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an enthesis at the bone-tendon junction. Stimulated MSCs can
produce cartilage and fibrocartilage in vitro [31–36] but it is not
clear just how they act. Gulotta et al. [27] tracked the cells with
transduced MSCs and found that they became concentrated in the
site of repair, but that there number decreased with time. They
may induce the production of a neo-enthesis without any
differentiation by releasing paracrine factors that recruit host cells
to restore the enthesis. This seems to occur after a myocardial
muscle lesion [37]. MSCs may also stimulate the rapid
reconstruction of an enthesis. We find that chondrocytes produced
type II collagen earlier than did MSCs, and the repaired insertion
Figure 4. Restoration of enthesis organization by MSC-injection 45 days post repair. Immunohistochemical staining for collagen II was
performed on native entheses (A) and 45 days post-repair enthesis from control G1 (B), chondrocyte-injected G2 (C) and MSC-injected G3 rats (D). A)
Native enthesis contained columns of chondrocytes (arrows) at the bone-tendon junction and there was positive collagen II immunostaining at the
junction. B) Control bone-tendon junction 45 days after surgery showing the absence of both cells and type collagen II. In contrast, the bone-tendon
junctions of repairs with cells injected were intensely stained for collagen II (C and D). However, the collagen II distribution was not uniform and there
were no chondrocyte columns in chondrocyte-injected rats (C), whereas the repairs of MSC-injected rats 45 days after surgery showed uniform type II
collagen distribution at the bone-tendon junction and the chondrocytes formed columns (arrows) (D). Scale =200mm. T, tendon; Bo, bone. Dotted
lines delimitate bone and tendon.
doi:10.1371/journal.pone.0012248.g004
Table 1. Histological scale used to assess the tissue engineering of the enthesis.
Scoring
Cell at bone-tendon
junction
Collagen II at bone-
tendon junction GAG content Collagen organization Chondrocyte organization
1 No ,2 5 % N oN oN o c e l l s
2 Clusters 25 to 50% Isolated area Isolated patches around
few cells
Isolated cells
3 Large areas 50 to 75% Large areas Focal area Clusters
4 Over the whole junction .75% Over the whole junction Covering bone-tendon
junction
In columns
The first 3 columns are visual grades assigned by examining x 25 images of the bone-tendon junction. The last 2 columns are assessments of x 100 images. The first
column uses sections stained with H&E and the second immunostained for type II collagen. The third column sections were stained with Alcian Blue. Columns 1 to 3
were used to define the production of an enthesis. Columns 2 to 5 were used to rank the organization of the neo-enthesis (16-point scale). The native enthesis always
scored 16 points in double blind trials (SD=0).
doi:10.1371/journal.pone.0012248.t001
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produced by the MSCs. However, the type II collagen and GAG
production in insertions repaired with chondrocytes and MSCs
was the same 45 days post-repair. Nevertheless, the structure of
entheses induced in vivo with MSCs was better (Fig. 4).
Histologically, the structure of MSC-induced entheses was very
similar to that of native entheses, more so than the chondrocyte-
induced entheses. Lastly, repairs made with MSCs gave better
load-to-failure values than did repairs made with chondrocytes
(Fig. 5), although the difference was not significant. We suggest
that the presence (and perhaps better organization) of type II
collagen fibers and chondrocytes seen on histology results in
greater strength. MSCs seem to be more effective than
chondrocytes at regenerating the enthesis so that the tendon is
bound strongly to the bone, restoring the histological appearance
of the native fibrocartilage.
Materials and Methods
Material
All reagents were purchased from Sigma-Aldrich (St Quentin
Fallavier, France), unless stated otherwise. Fetal calf serum (FCS)
was from Invitrogen (Cergy Pontoise, France). Collagenase D was
from Roche Diagnostics (Meylan, France).
Experimental rat model of degenerative enthesis model
repair
All animal experiments complied with the regulations of the
Ethical Committee of the Pierre & Marie Curie University animal
welfare Department. Approval (P3/2008/003) (Comite ´R e ´gional
d’e ´thique pour l’expe ´rimentation animale, Ile de France – Paris –
Comite ´ 3).
Male Wistar rats (300 g, 3 months old; supplied by Janvier,
Orle ´ans, France) were anesthetized and the Achilles tendon of the
left leg was exposed and released from the calcaneum. The tendon
was cut at its insertion on the bone, and the enthesis was destroyed
with a burr (Fig. 1D). A sterile needle (BD microlanceH, 23G) was
used to make 2 tunnels through the calcaneum and a 4/0 non-
absorbable (4/0 Ethibond) suture was used to attach the tendon
back to the bone (Fig. 6A, B). The wound was then closed. The
rats were given a pain killer and allowed to recover. They were
housed 2 to a cage and allowed to move without restriction. Rats
were sacrificed 15, 30 and 45 days after surgery.
A total of 142 rats underwent surgery and were assigned to 1 of
3 experimental groups, as follows: G1, no cells injected (n=52),
G2, chondrocytes injected (n=51) and G3, MSCs injected (n=39)
at the site of repair just before tightening the suture. Because some
rats died and some biomechanical tests or histological assessments
failed, surgery was performed to obtain 6 successful biomechanical
tests per group and period, and 4 histological assessments per
group and recovery time.
Cell injection
Freshly isolated chondrocytes and expended MSCs (passage 4)
were suspended in bovine fibrinogen (40 mg/mL, Sigma) in
phosphate-buffered saline (PBS) and mixed with an equal volume
of bovine thrombin solution (20 UI/mL, Sigma) [38–40] to obtain
a final concentration of 4610
6 cells/100 mL) [12,38,40]. The
solution was prepared during surgery, and injected (100 mL) at the
site of repair just before tightening the suture.
Cell preparation and characterization
Chondrocyte. Hip and knee cartilages from 4 day-old Wistar
rats were harvested as previously described [39]. Briefly, rats were
killed by injecting 0.1 mL phenobarbital. The skin on the back
and legs was cleaned with antiseptic and removed under sterile
conditions. The femurs were dislocated, and the soft tissues around
the joints were discarded. Hip and knee cartilages were removed
and washed in PBS containing 1% antibiotic. The femoral heads,
femoral condyles, and tibial plateaux isolated from two litters (15
rats) were incubated in Dulbecco’s Modified Eagle’s Medium
supplemented with 2 mM L-glutamine, 50 U/mL penicillin and
0.05 mg/mL streptomycin 2 times for 45 min with collagenase D
(3 mg/mL) and overnight with collagenase D (0.5 mg/mL) at
37uC under 5% CO2: 95% air. The resulting cell suspension was
mixed to disperse cell aggregates, filtered through a sterile 60 mm
filter and centrifuged for 10 min at 1500 rpm. The chondrocytes
so collected were washed in PBS, suspended in culture medium
supplemented with 10% FCS and counted in a hemocytometer.
The average yield per rat was 10
6 chondrocytes, of which more
than 97% excluded Trypan blue. The chondrocytes were injected
the day after harvesting to prevent dedifferentiation.
In parallel, cells were seeded on a culture dish (8610
3 cells/
cm
2) to confirm their chondrocyte phenotype. At confluence (7
days after seeding), cells showed the typical chondrocyte
morphology with a rounded or polygonal shape and granular
cytoplasm. The chondrocyte phenotype was confirmed by
immunostaining for type II collagen (Chondrex, Redmond, WA,
USA) (Fig. 7) and by Alcian Blue staining for sulfated
proteoglycans. Alkaline phosphatase staining was performed to
demonstrate that there were no bone cells in the primary cultures.
Mesenchymal Stem Cells. MSCs were obtained from 4
day-old Wistar rats. The lower limbs were removed as described
above and the femur and tibia shafts were immediately placed in a
sterile hood and flushed with MSC medium (alpha MEM
supplemented with 1% alpha glutamine, 1% antibiotic, 10%
Hyclone SVF) containing heparin (5 IU/mL).This solution was
passed through a 60 mm filter and centrifuged for 10 min at
1500 rpm. The resulting cells were washed 3 times in PBS
containing 1% antibiotic and seeded on 75 cm
2 plates for 48 h.
Figure 5. Global results of the study reporting evolution of the
histology scoring, failure to load and global healing rate for
each population at 45 days. This graph shows the results of each
item at 45 days of treatment. The left columns are the data reported for
a native enthesis, for animal of the same age as those tested. This graph
illustrates the importance of the MSC. While the overall healing rates for
the chondrocyte-treated and MSC-treated rats are the same, histolog-
ical scores and load-to-failure rates of the MSC-treated rats are better
than those of the chondrocyte-treated rats.
doi:10.1371/journal.pone.0012248.g005
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adhering stem cells. The medium was subsequently changed every
other day. After 4 passages, MSCs were injected and their
phenotype was confirmed.
Cells were cultured on sterile round cover slips placed in 24-well
plates. The confluent cells were fixed with 4% neutral buffered
formalin. We used the ChemiconR Mesenchymal Stem Cell
Characterization Kit (Chemicon, USA) to demonstrate the
presence of markers of rat MSCs (integrin b1, CD54, fibronectin
and type I collagen) and the absence of hematopoietic cell surface
markers (CD14 and CD45) (Fig. 7).
Overall healing rate
Healing failure at sacrifice was defined by one of three criteria:
1) the proximal migration of the tendon with a gap between the
tendon and the bone, 2) suture rupture (Fig. 1E and F), and 3) a
distance of .1 cm between the bone and the muscle. The overall
healing rate was assessed in a double blind analysis (by CS
Figure 6. Enthesis repair after destruction and mechanical loading. (A and B) The tendon was retained by a sutures passing through the
tendon and two tunnels in the calcaneus bone after destruction of the enthesis. The tunnels were made using a 23G sterile needle (A) and a 4/0 non
absorbable suture was passed through the hole to attach the tendon to the bone (B). The plantar side of the calcaneum was placed on a metal rod.
The box was fixed to a triangular piece of metal and the fiber part of the muscle was removed, leaving only its aponevrosis fixed in a double-sided
tape (C). The proximal tip of the calcaneum was placed on the machine, two CCD cameras were placed at 90u around the sample (frontal and lateral
to the calcaneum) to check the positioning (D and E)). A load-to-failure curve was obtained for each sample tested (F).
doi:10.1371/journal.pone.0012248.g006
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was 1.0, demonstrating no inter-observer difference.
Mechanical analysis
Samples composed of the calcaneum, tendon and distal part of
the muscle were removed as a unit at sacrifice. They were placed
in a moist paper and plastic wrap and stored at –20uC. Samples
were thawed at room temperature before mechanical testing. Tests
were performed under near-physiological conditions [41] by
applying force to the tendon positioned at 135u with respect to
the plantar side of the calcaneum [42] using a custom made
device.
The plantar side of the calcaneum was placed on a 3 mm
diameter vertical metal rod placed in a box (13613610 mm)
(Fig. 6). The distal part of the calcaneum was embedded in dental
resin (Lang Dental, Wheeling, IL, USA), leaving at least 3 mm of
its proximal part outside the resin (Fig. 6). The box was fixed to a
triangular piece of metal so that the plantar side of the calcaneum
was at 135u to the axis of traction of the testing machine (model
5565; Instron, Canton, MA, USA).
The triangular base was mounted on an adjustable platform
that enabled the tendon to be aligned with the machine axis. The
proximal tip of the calcaneum was placed on the machine axis
indicated by a needle. Two CCD cameras placed at 90u around
the sample (frontal and lateral to the calcaneum) were used to
check the positioning (Fig. 6).
The fiber part of the muscle was removed, leaving only its
aponevrosis. Double-sided tape was placed on this aponevrosis so
as to leave 3 mm of tendon free for testing. The double-sided tape
was placed in custom made striated jaws fixed in the machine axis.
The initial length of the sample was defined for a preload of
0.1 N. Samples were then loaded at a traction rate of 10 mm/min
until failure. They were tested at room temperature and kept moist
throughout the test.
The load-to-failure of the healed bone-tendon insertion in the
tensile test was the main parameter measured 15, 30 and 45 days
after surgery. We used 6 to 8 samples for the final data analysis at
each time for each group (G1, G2, G3).
Reference data were obtained by testing 6 unoperated samples
(native enthesis) from 4.5 month-old rats to determine the natural
load-to-failure of the bone-tendon insertion of the rat Achilles
tendon.
Histological data
Samples were fixed in 3.7% paraformaldehyde, decalcified and
embedded in paraffin. 5 mm sections were cut in the same sagittal
plane and immunostained for type II collagen and Alcian Blue
staining for GAG, as described [43].
Neo-enthesis production and organization were analyzed using
two histological scales. First, neo-enthesis production at 15, 30 and
45 days was assessed by measuring type II collagen production at
the bone-tendon junction, the GAG content and cell deposition
(magnification 625) (table 1, first three columns). Second, the
organization of the enthesis 45 days after surgery was quantified
on 4 samples from each group (magnification 6100). Histological
scores (1 to 4) were given for each of the following criteria: 1) the
percentage contact between bone and tendon with type II collagen
production, 2) type II collagen organization, 3) chondrocyte
organization and 4) GAG production (table 1). A total score of less
than 5 indicated the absence of an enthesis as in the samples whose
enthesis had been destroyed; the histological slides of native
enthesis routinely scored 16 (p,0.05).
A blinded analysis was performed by three of the authors. The
inter-observer variation of the histological scale was very small,
Figure 7. MSC and chondrocyte immuno-characterization. Fluorescent immunostaining. A: type II collagen around chondrocytes and its
negative control: B. C: Type I collagen of rat MSCs. D: Fibronectin in rat MSCs. E: Integrin b1 in rat MSCs. F: CD54 in rat MSCs. G: CD45 negative
immunostaining of rat MSCs. H: CD14 negative immunostaining of rat MSCs. Scale is 100 mm.
doi:10.1371/journal.pone.0012248.g007
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213).
Student’s t-test showed non-significant p values between criteria,
meaning that one criterion was not responsible for the positive or
negative nature of any other. Three criteria were correlated: the
percentage contact between the bone and tendon, type II collagen
production and cells at the bone tendon junction (p,10
26). The
percentage of bone-tendon contact was correlated with type II
collagen production and the GAG content (p,0.002). These
correlations are not surprising as the cells were added to produce a
matrix rich in type II collagen and GAG.
Statistics
Results are expressed as means 6 SD. We used a one-tailed
Student’s t-test to compare the load-to-failure data for native, G1,
G2 and G3 rats at each time. The overall healing rate was
assessed using Pearson’s Chi-squared test. Histological data
underwent statistical analysis. Intra-observer reproducibility was
evaluated with a one-tailed Student’s t-test on correlation
coefficients. We also performed one-tailed Student’s t-tests to
demonstrate the independence of each item of the scale and to
compare the histological scores of the groups. Significance was set
at p,0.05.
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